(Q35523678)

8 August 2017

title

Is ApoE epsilon4 associated with cognitive functioning in African Americans diagnosed with Alzheimer Disease? An exploratory study (English)

1 reference

8 August 2017

0 references

David L Mount

1

1 reference

8 August 2017

Angela V Ashley

2

1 reference

8 August 2017

James J Lah

3

1 reference

8 August 2017

Allan I Levey

4

1 reference

8 August 2017

Felicia C Goldstein

5

1 reference

8 August 2017

language of work or name

English

1 reference

inferred from

Southern Medical Journal

publication date

1 September 2009

1 reference

8 August 2017

published in

Southern Medical Journal

1 reference

8 August 2017

volume

102

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

890-893

1 reference

Perspective on race and ethnicity in Alzheimer's disease research.

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

Deconstructing race and ethnicity: implications for measurement of health outcomes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

The clinical validity of the Mattis Dementia Rating Scale in staging Alzheimer's dementia.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

Cognitive impairment in Alzheimer's disease is modified by APOE genotype.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

Neuropsychological test performance in African-American and white patients with Alzheimer's disease.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

The effect of APOE genotype on clinical phenotype in Alzheimer disease

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4406227

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI

15 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19668025

12 December 2020

inferred from PubMed ID database lookup

No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19668025

12 December 2020

inferred from PubMed ID database lookup

The effect of APOE genotype on clinical phenotype in Alzheimer disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19668025

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1097/SMJ.0B013E3181B21B82

1 reference

release_rypz72tmyfflpms4kqs2ho2yd4

8 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rypz72tmyfflpms4kqs2ho2yd4

24 November 2022

mapped directly with Wikidata item

PMC publication ID

4406227

1 reference

8 August 2017

1 reference